Ranbaxy Board Approves Separate Research Unit, Plans Share Listing This Year
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Ranbaxy Laboratories' board Feb. 19 approved setting up a research unit called Ranbaxy Life Science Research Ltd., the latest foray by Indian generic pharma firms to create dedicated research and development arms to cut expenses on the parent balance sheet and attract new contract business